HOME >> MEDICINE >> NEWS
San Francisco VA researcher receives top Veterans Affairs award

Michael Weiner, MD, a pioneering brain imaging researcher at the San Francisco VA Medical Center (SFVAMC), is a recipient of the 2006 William S. Middleton Award from the Department of Veterans Affairs.

The award the VA's highest scientific honor is given in recognition of outstanding achievement in biomedical research. It was named after the physician who served as the VA's Chief Medical Officer from 1955 to 1963.

Weiner is director of the Center for the Imaging of Neurodegenerative Diseases (CIND) at SFVAMC and a professor of radiology, medicine, psychiatry, and neurology at the University of California, San Francisco (UCSF).

He will receive the award officially on May 15, 2007 in a ceremony in Washington, DC.

As a 2006 recipient, Weiner will receive $50,000 per year for three years in research support, a cash award of $5,000, an announcement of the award in a prestigious scientific journal, and an inscribed plaque commemorating his scientific achievements. SFVAMC will also receive a plaque honoring Weiner's achievements.

Weiner is to be recognized for his "exemplary service to the VA and to the biomedical profession" as well as his contributions to the field of clinical magnetic resonance imaging.

Weiner, a nephrologist by training, joined SFVAMC in 1980 as chief of hemodialysis. In the same year, he first worked with nuclear magnetic resonance (NMR) technology to obtain images of a kidney in a living rat one of the earliest biological applications of NMR. He went on to establish the magnetic resonance imaging program at SFVAMC, and has had a hand in the development of clinical magnetic resonance brain imaging techniques used around the world.

Currently, Weiner is the primary principal investigator of the Alzheimer's Disease Neuroimaging Initiative, a nationwide, multicenter clinical trial designed to establish a brain biomarker for Alzheimer's disease. He is also the principal investigator
'"/>

Contact: Steve Tokar
steve.tokar@ncire.org
415-221-4810, ext. 5202
University of California - San Francisco
15-May-2007


Page: 1 2

Related medicine news :

1. San Franciscos homeless population is getting older
2. San Francisco VA Medical Center invites public to celebrate VA Research Week
3. UC San Franciscos Harrington wins GSAs 2005 Doris Schwartz Gerontological Nursing Award
4. Stanford researchers find culprit in aging muscles that heal poorly
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Penn researchers discover novel pathway for increasing good cholesterol
7. Theory of facial aging gets a facelift from UT Southwestern researchers
8. UIC researchers to develop new drugs to fight bioterrorism
9. Fat is the new normal, FSU researcher says
10. UQ researchers discover some of the oldest forms of life
11. U of M researchers discover new method to combat HIV

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: San Francisco researcher receives top Veterans Affairs award

(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians and ... and musculoskeletal diseases gathered here for the World ... time in the 17-year history of the field’s ... is an emerging non-pharmaceutical protocol for enhancing bone ... Wolff’s law, osteogenic loading at multiples of body ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Cached News: